ICPO CENTERS
SUPPORT

The ICPO Foundation offers a structured accreditation pathway that recognizes centers‘ current achievements and also engages in providing a clear roadmap for future development, based on assessment and interaction with the individual centers in their local context. Whether a center is newly established or already a global leader, this framework ensures adequate support at every stage, enhancing growth and strengthening expertise in Theranostics.

Supporting Growth Path from Clinical to Comprehensive Center by:

  • Optimizing workflow and process designs
  • Analyzing multidisciplinary tumor boards effectiveness
  • Increasing patient referrals and external visibility

Enhancing Local Networks and Visibility for ICPO Theranostics Centers by:

  • Organizing a Theranostics Day at the Theranostics Center
  • Engaging with multidisciplinary colleagues & referring physicians
  • Increasing awareness of local patient associations

Empowering Theranostics Healthcare Professionals by:

  • Offering certified e-Education through the ICPO Academy for Theranostics
  • Providing free access to the ICPO Academy via industry sponsored stipends
  • Accessing Observational Theranostics Trainings

ICPO CENTERS VOICES

  • Cecilia_Carreras
    “Collaborating with the ICPO Foundation, our theranostics center is leading a transformative shift toward precision oncology in South Africa. As an ICPO Theranostics Clinical Center, we benefit from the global community and exchange with world-class experts within the foundation.”
    Prof. Mike Sathekge, CEO of Nuclear Medicine Research Infrastructure, Univ. of Pretoria, South Africa
    1 2 3
  • Cecilia_Carreras
    “Joining the ICPO Theranostics Centers of Excellence Network marks an important step in our commitment to advancing precision oncology in Jordan. Being part of this international community allows us to share expertise, be at the forefront of the latest developments in Theranostics and collaborate with other leading centers worldwide. With this collaboration we ensure that more patients benefit from cutting-edge, personalized cancer care.”
    Prof. Akram Al-Ibraheem, Chairman of the Nuclear Medicine Department at Jordan‘s King Hussein Cancer Center, Amman, Jordan and President of AOFNMB
  • Cecilia_Carreras
    “The best way to move forward is to team up with committed people, with common principles and ideals. At Hospital Angeles Lomas we are honored to have joined the ICPO Clinical Theranostics Center Network. This alliance will allow us to strengthen educational strategies, improve access to Theranostics and offer better treatment options, with a patient-centered approach”.
    Dr. Cecilia Carreras, Head of Nuclear Medicine, Hospital Angeles Lomas, Mexico City, Mexico
menuchevron-downarrow-upcross-circle